Robert Ho
2021 - Aquinox Pharmaceuticals
In 2021, Robert Ho earned a total compensation of $1.5M as Former Chief Financial Officer at Aquinox Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,336 |
|---|---|
| Salary | $396,266 |
| Stock Awards | $949,531 |
| Other | $4,300 |
| Total | $1,505,433 |
Ho received $949.5K in stock awards, accounting for 63% of the total pay in 2021.
Ho also received $155.3K in non-equity incentive plan, $396.3K in salary and $4.3K in other compensation.
Rankings
In 2021, Robert Ho's compensation ranked 7,251st out of 12,406 executives tracked by ExecPay. In other words, Ho earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,251 out of 12,406 | 42nd |
Division Manufacturing | 3,183 out of 5,492 | 42nd |
Major group Chemicals And Allied Products | 1,410 out of 2,368 | 41st |
Industry group Drugs | 1,254 out of 2,089 | 40th |
Industry Pharmaceutical Preparations | 920 out of 1,536 | 40th |
Source: SEC filing on March 31, 2022.
Ho's colleagues
We found two more compensation records of executives who worked with Robert Ho at Aquinox Pharmaceuticals in 2021.